Deep Brain Stimulation for Essential Tremor
(rT DBS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a treatment called Deep Brain Stimulation (DBS) for individuals with hard-to-treat tremors. The goal is to determine if electrical pulses deep in the brain can safely and effectively manage tremors unresponsive to other treatments. Individuals who have struggled with tremors for at least three years and find daily tasks challenging due to the tremors might be suitable candidates. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the opportunity to be among the first to receive this innovative treatment.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, since the trial is for tremors that are not controlled by medication, it's possible you may continue your current treatment. Please consult with the trial coordinators for specific guidance.
What prior data suggests that this device is safe for treating refractory tremor?
Studies have shown that deep brain stimulation (DBS) is generally safe for people with movement disorders, such as essential tremor. Research involving over 1,000 patients with Parkinson's disease who received DBS demonstrated improved movement abilities. For essential tremor, other studies with 430 patients reported that most side effects were mild and easily managed.
This suggests that while DBS carries some risks, it is usually well-tolerated. This trial uses the Medtronic Percept RC DBS System, a device already familiar in the medical field, which may reassure participants about its safety. However, this specific trial is in its early stages. As with any treatment, discussing potential risks and benefits with the trial team before participating is important.12345Why do researchers think this study treatment might be promising?
Researchers are excited about Deep Brain Stimulation (DBS) for Essential Tremor because it offers a unique approach compared to standard treatments like beta-blockers, anti-seizure medications, or focused ultrasound. Unlike these medications, which often work by dampening nerve signals throughout the body, DBS directly targets the brain regions responsible for tremor by delivering electrical impulses. This precise targeting can lead to more effective tremor control with potentially fewer side effects. Additionally, the DBS system used in this trial, the Medtronic Percept RC, features advanced sensing technology that allows for more personalized treatment adjustments.
What evidence suggests that deep brain stimulation might be an effective treatment for essential tremor?
Research shows that deep brain stimulation (DBS), which participants in this trial will receive, can greatly reduce tremor symptoms. For people with essential tremor (ET), studies have found that DBS improves shaking and hand movement, with benefits lasting for years. In one study, patients experienced a 59% reduction in tremor after treatment. Additionally, a multi-center study found that DBS improved symptoms and quality of life for those with ET. This evidence supports the potential effectiveness of DBS for treating tremors that don't respond to other treatments.35678
Are You a Good Fit for This Trial?
This trial is for patients with severe tremors that haven't improved after treatments like Vim DBS or HIFU thalamotomy, or those who can't have these treatments due to specific types of tremor related to cerebellar outflow or multiple sclerosis (MS).Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
DBS Implant Surgery
Participants undergo surgery for the implantation of the Medtronic Percept RC Deep Brain Stimulation System
Treatment
Participants receive electrical stimulation of the deep cerebellar nuclei for refractory tremor
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Deep Brain Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Cleveland Clinic
Lead Sponsor
Medtronic
Industry Sponsor
Geoff Martha
Medtronic
Chief Executive Officer since 2020
Finance degree from Penn State University
Dr. Richard Kuntz
Medtronic
Chief Medical Officer since 2023
MD, MSc
Raynor Cerebellum Project
Collaborator